Ameritas Investment Partners’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.6K | Hold |
7,594
| – | – | ﹤0.01% | 1761 |
|
|
2025
Q1 | $167K | Hold |
7,594
| – | – | 0.01% | 1382 |
|
|
2024
Q4 | $203K | Buy |
7,594
+482
| +7% | +$12.9K | 0.01% | 1315 |
|
|
2024
Q3 | $190K | Hold |
7,112
| – | – | 0.01% | 1360 |
|
|
2024
Q2 | $128K | Buy |
7,112
+1,361
| +24% | +$24.5K | ﹤0.01% | 1574 |
|
|
2024
Q1 | $105K | Buy |
5,751
+1,561
| +37% | +$28.5K | ﹤0.01% | 1706 |
|
|
2023
Q4 | $45.8K | Hold |
4,190
| – | – | ﹤0.01% | 2223 |
|
|
2023
Q3 | $24K | Buy |
4,190
+1,200
| +40% | +$6.88K | ﹤0.01% | 2453 |
|
|
2023
Q2 | $23.2K | Hold |
2,990
| – | – | ﹤0.01% | 2490 |
|
|
2023
Q1 | $19.9K | Hold |
2,990
| – | – | ﹤0.01% | 2470 |
|
|
2022
Q4 | $31.7K | Hold |
2,990
| – | – | ﹤0.01% | 2335 |
|
|
2022
Q3 | $29K | Hold |
2,990
| – | – | ﹤0.01% | 2322 |
|
|
2022
Q2 | $23K | Hold |
2,990
| – | – | ﹤0.01% | 2484 |
|
|
2022
Q1 | $29K | Hold |
2,990
| – | – | ﹤0.01% | 2382 |
|
|
2021
Q4 | $46K | Buy |
2,990
+2,023
| +209% | +$31.1K | ﹤0.01% | 2177 |
|
|
2021
Q3 | $16K | Hold |
967
| – | – | ﹤0.01% | 2801 |
|
|
2021
Q2 | $21K | Buy |
+967
| New | +$21K | ﹤0.01% | 2704 |
|